Care homes in Brazil are looking to avoid the mistakes made in Europe, and are lobbying government to ensure there are medical facilities available for elderly patients showing signs of COVID-19. If isolation within care homes in Europe didn't work, and it clearly hasn't, it will be impossible in Brazil they say.
As HBI Intelligence reviews the impact of COVID-19, HBI has been talking to operators and analysts. One EU-based operator says many markets across Europe will struggle to recover once the COVID-19 crisis has passed. Here is his view of where will be worst hit - and where we may see a surprising rebound.
Cancer companies in the UK do not have a contract with the NHS to take 20,000 public patients, despite an earlier report to the contrary in a UK broadsheet newspaper. Providers tell HBI that they fear that a mass of 'second-wave deaths' and look at how pressure might transform clinical pathways in oncology.
As COVID-19 surges in Europe beyond the (reported) levels in its source country and across emerging markets, government utilisation of private hospital capacity is a mixed picture. And there are discussions about the possibility of wholesale requisitions of private capacity in emerging markets with under-resourced public healthcare systems.
Spain has passed a law enabling regional governments to seize control of private facilities. Portugal has passed a similar law. Meanwhile, HM Hospitales, the second largest group faces a backlash after suggesting now would be a good time for its staff to go on holiday.
COVID-19 is forcing European laboratories to re-think where they test patients. Some are working with authorities to set up new ‘drive-through’ testing points, while others have closed more than half of their drawing points.
Reports from Spain suggest Spain’s biggest dental chain by revenue, Dentix, has an uncertain future after a rescue plan by Vitaldent owner Advent fell through.
In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
